文献速递脑血管病

基线CTA血栓负荷评分与急性缺血性卒中动脉内治疗效应的关系

Clot Burden Score on Baseline Computerized Tomographic Angiography and Intra-Arterial Treatment Effect in Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2016-11-08

该研究为MR CLEAN试验的事后探索性分析,纳入499例急性缺血性卒中患者,评估基线CTA血栓负荷评分(CBS)与神经功能改善及血管内治疗效应的关系。结果显示,较高的CBS与改良Rankin量表结局改善相关(每点调整共同OR 1.12,95%CI 1.04-1.20),但未发现CBS改变动脉内治疗效应的证据。

要点

  • 较高CBS与急性缺血性卒中患者改良Rankin量表结局改善独立相关。
  • CBS每增加1点,调整共同OR为1.12(95%CI 1.04-1.20)。
  • 未发现CBS显著改变动脉内治疗效应的证据。

核心结论

  • 较高的CBS与急性缺血性卒中患者结局改善相关,可作为预后标志物。
  • 未发现CBS改变动脉内治疗效应的证据。

研究设计与样本

  • MR CLEAN研究的事后探索性分析,纳入499例急性缺血性卒中患者。
  • 使用有序逻辑回归模型评估CBS与改良Rankin量表结局的关联,并检验CBS与治疗的交互作用。

主要发现

  • 较高的CBS与改良Rankin量表结局改善相关,每点CBS的调整共同OR为1.12(95%CI 1.04-1.20)。
  • 二分类CBS(以6为界)的调整共同OR为1.67(95%CI 1.12-2.51)。
  • 加入基线预后变量后,上述效应估计值略有衰减。
  • 交互项未显著改善模型拟合,高CBS组动脉内治疗疗效有小幅但不显著的增加。

临床怎么用

  • CBS可作为急性缺血性卒中患者的预后标志物。
  • CBS不宜用于筛选可能从动脉内治疗中获益更多的患者。

局限性

  • 本研究为事后探索性分析。
  • 交互作用检验未显示显著效应,不能排除把握度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: A high clot burden score (CBS) is associated with favorable outcome after intravenous treatment for acute ischemic stroke. The added benefit of intra-arterial treatment might be less in these patients. The aim of this exploratory post hoc analysis was to assess the relation of CBS with neurological improvement and endovascular treatment effect. METHODS: For 499 of 500 patients in the MR CLEAN study (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), the CBS was determined. Ordinal logistic regression models with and without main baseline prognostic variables were used to assess the association between CBS (continuous or dichotomized at CBS of 6) and a shift toward better outcome on the modified Rankin Scale. The model without main baseline prognostic variables only included treatment allocation and CBS. Models with and without a multiplicative interaction term of CBS and treatment were compared using the χ2 test to assess treatment effect modification by CBS. RESULTS: Higher CBS was associated with a shift toward better outcome on the modified Rankin Scale; adjusted common odds ratio per point CBS was 1.12 (95% confidence interval, 1.04-1.20]. Dichotomized CBS had an adjusted common odds ratio of 1.67 (95% confidence interval, 1.12-2.51). Both effect estimates were slightly attenuated by adding baseline prognostic variables. The addition of the interaction terms did not significantly improve the fit of the models. There was a small and insignificant increase of intra-arterial treatment efficacy in the high CBS group. CONCLUSIONS: A higher CBS is associated with improved outcome and may be used as a prognostic marker. We found no evidence that CBS modifies the effect of intra-arterial treatment. CLINICAL TRIAL REGISTRATION: URL: http://www.trialregister.nl. Unique identifier: NTR1804. URL: http://www.controlled-trials.com. Unique identifier: ISRCTN10888758.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Treurniet KM, Yoo AJ, Berkhemer OA, et al. Clot Burden Score on Baseline Computerized Tomographic Angiography and Intra-Arterial Treatment Effect in Acute Ischemic Stroke. Stroke. 2016. PMID: 27827328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。